id: pfos_serum_concentration_to_pr_positive_breast_cancer
name: Serum Perfluorooctane Sulfonate (PFOS) Concentration â†’ Progesterone Receptor
  Positive (PR+) Breast Cancer
from_node:
  node_id: pfos_serum_concentration
  node_name: Serum Perfluorooctane Sulfonate (PFOS) Concentration
to_node:
  node_id: pr_positive_breast_cancer
  node_name: Progesterone Receptor Positive (PR+) Breast Cancer
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: PFOS acts as endocrine disruptor affecting progesterone signaling pathways'
- 'Step 2: Persistent chemical exposure accumulates through environmental contamination
  in water, soil, and food supply'
- 'Step 3: Disrupted progesterone receptor function alters breast tissue cell proliferation
  and differentiation'
- 'Step 4: Chronic endocrine disruption increases susceptibility to PR+ tumor development'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'V. Chang et al. 2023. "Serum perfluorooctane sulfonate and perfluorooctanoate
    and risk of postmenopausal breast cancer according to hormone receptor status:
    An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial."
    *International Journal of Cancer*. https://doi.org/10.1002/ijc.34487'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.490432'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: exposure_quartile
  direction: strengthens
  strength: strong
  description: Third quartile PFOS showed strongest association with PR+ tumors (OR=2.34,
    95% CI 1.29-4.23), representing over 2-fold increased risk
